Modification of oral absorption of oxyresveratrol using lipid based nanoparticles

Colloids and Surfaces B: Biointerfaces

Volumn 131, Issue , 2015, Pages 182-190

  Sangsen, Yaowaporn ^a   Wiwattanawongsa, Kamonthip ^a   Likhitwitayawuid, Kittisak ^b   Sritularak, Boonchoo ^b   Wiwattanapatapee, Ruedeekorn ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Nanostructured lipid carriers; Oral absorption; Oxyresveratrol; Solid lipid nanoparticles

Indexed keywords

BIOCHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG PRODUCTS; HOMOGENIZATION METHOD; X RAY DIFFRACTION; ZETA POTENTIAL;

HIGH SHEAR HOMOGENIZATIONS; NANOSTRUCTURED LIPID CARRIER (NLC); NANOSTRUCTURED LIPID CARRIERS; ORAL ABSORPTION; OXYRESVERATROL; POWDER X-RAY DIFFRACTION (PXRD); RELATIVE BIOAVAILABILITY; SOLID LIPID NANOPARTICLE (SLN);

NANOPARTICLES;

NANOCARRIER; NANOSTRUCTURED LIPID CARRIER; OXYRESVERATROL; SOLID LIPID NANOPARTICLE; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; DRUG CARRIER; LIPID; NANOPARTICLE; PLANT EXTRACT; PUAG-HAAD;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG EXPOSURE; DRUG FORMULATION; DRUG STABILITY; ENTEROHEPATIC CIRCULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SUSPENSION; SUSTAINED DRUG RELEASE; TIME TO MAXIMUM PLASMA CONCENTRATION; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; ELECTRIC CONDUCTIVITY; INTESTINE ABSORPTION; KINETICS; ORAL DRUG ADMINISTRATION; STATIC ELECTRICITY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; WISTAR RAT; X RAY DIFFRACTION;

RATTUS NORVEGICUS;

ADMINISTRATION, ORAL; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG CARRIERS; ELECTRIC CONDUCTIVITY; INTESTINAL ABSORPTION; KINETICS; LIPIDS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; PLANT EXTRACTS; RATS, WISTAR; STATIC ELECTRICITY; STILBENES; X-RAY DIFFRACTION;

EID: 84929319404     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.04.055     Document Type: Article

References (42)

1. Chung K.O., Kim B.Y., Lee M.H., Kim Y.R., Chung H.Y., Park J.H., Moon J.O. J. Pharm. Pharmacol. 2003, 55:1695.
2. Lorenz P., Roychowdhury S., Engelmann M., Wolf G., Horn T.F.W. Nitric Oxide 2003, 9:64.
3. Tengamnuay P., Pengrungruangwong K., Pheansri I., Likhitwitayawuid K. Int. J. Cosmet. Sci. 2006, 28:269.
4. Weber J.T., Lamont M., Chibrikova L., Fekkes D., Vlug A.S., Lorenz P., Kreutzmann P., Slemmer J.E. Eur. J. Pharmacol. 2012, 680:55.
5. Likhitwitayawuid K., Sritularak B., Benchanak K., Lipipun V., Mathew J., Schinazi R.F. Nat. Prod. Res. 2005, 19:177.
6. Lipipun V., Sasivimolphan P., Yoshida Y., Daikoku T., Sritularak B., Ritthidej G., Likhitwitayawuid K., Pramyothin P., Hattori M., Shiraki K. Antivir. Res. 2011, 91:154.
7. Sasivimolphan P., Lipipun V., Likhitwitayawuid K., Takemoto M., Pramyothin P., Hattori M., Shiraki K. Antivir. Res. 2009, 84:95.
8. Liu A.L., Yang F., Zhu M., Zhou D., Lin M., Lee S.M.Y., Wang Y.T., Du G.H. Planta Med. 2010, 76:1874.
9. Qiu F., Komatsu K., Saito K., Kawasaki K., Yao X., Kano Y. Biol. Pharm. Bull. 1996, 19:1463.
10. Mei M., Ruan J.Q., Wu W.J., Zhou R.N., Lei J.P.C., Zhao H.Y., Yan R., Wang Y.T. J. Agric. Food Chem. 2012, 60:2299.
11. Charoenlarp P., Shaipanich C., Subhanka S., Lakkantinaporn P., Tanunkat A. Pharmacokinetics of the active constituent of Puag-haad in man. Symposium on Mahidol University Research and Development, ASEAN Institute Health Development 1991.
12. Huang H., Chen G., Lu Z., Zhang J., Guo D.A. Biomed. Chromatogr. 2010, 24:426.
13. Tanunkat A. Absorption Metabolism and Excretion of 2, 3, 4, 5 Tetrahydroxystilbene in Volunteers after Oral Administration of Purified Extract of Paug-Haad 1990, Mahidol University, Salaya, NakhonPathom, Thailand.
14. Chakraborty S., Shukla D., Singh S. Eur. J. Pharm. Biopharm. 2009, 73:1.
15. Fricker G., Kromp T., Wendel A., Blume A., Zirkel J., Rebmann H., Setzer C., Quinkert R.O., Martin F., Müller-Goymann C. Pharm. Res. 2010, 27:1469.
16. Li P., Nielsen H.M., Müllertz A. Expert Opin. Drug Deliv. 2012, 9:1289.
17. Müller R.H., Mäder K., Gohla S. Eur. J. Pharm. Biopharm. 2000, 50:161.
18. Tiwari R., Pathak K. Int. J. Pharm. 2011, 415:232.
19. Shono Y., Nishihara H., Matsuda Y., Furukawa S., Okada N., Fujita T., Yamamoto A. J. Pharm. Sci. 2004, 93:877.
20. Souto E.B., Müller R.H. Drug Delivery Handbook of Experimental Pharmacology 2010, vol. 197. Springer, Berlin, (Chapter 2).
21. Üner M. Pharmazie 2006, 61:375.
22. Almeida A.J., Souto E. Adv. Drug Deliv. Rev. 2007, 59:478.
23. Neves A.R., Lúcio M., Martins S., Lima J.L., Reis S. Int. J. Nanomed. 2013, 8:177.
24. Sangsen Y., Likhitwitayawuid K., Sritularak B., Wiwattanawongsa K., Wiwattanapatapee R. Int. J. Med. Sci. Eng. 2013, 7:103.
25. Ritger P.L., Peppas N.A. J. Control. Release 1987, 5:23.
26. Clark W.F., Parbtani A., Philbrick D.J., Holub B.J., Huff M.W. J. Am. Soc. Nephrol. 1991, 1:1343.
27. Mehnert W., Mäder K. Adv. Drug Deliv. Rev. 2001, 47:165.
28. Gokce E.H., Korkmaz E., Dellera E., Sandri G., Bonferoni M.C., Ozer O. Int. J. Nanomed. 2012, 7:1841.
29. Zhuang C.Y., Li N., Wang M., Zhang X.N., Pan W.S., Peng J.J., Pan Y.S., Tang X. Int. J. Pharm. 2010, 394:179.
30. Roger E., Lagarce F., Garcion E., Benoit J.P. J. Control. Release 2009, 140:174.
31. Chen C.C., Tsai T.H., Huang Z.R., Fang J.Y. Eur. J. Pharm. Biopharm. 2010, 74:474.
32. Akbari B., Pirhadi Tavandashti M., Zandrahimi M. IJMSE 2011, 8:48.
33. Jenning V., Thünemann A.F., Gohla S.H. Int. J. Pharm. 2000, 199:167.
34. Sutananta W., Craig D.Q.M., Newton J.M. J. Pharm. Pharmacol. 1995, 47:182.
35. Souto E.B., Mehnert W., Müller R.H. J. Microencapsul. 2006, 23:417.
36. Hu L.D., Xing Q., Meng J., Shang C. AAPS PharmSciTech 2010, 11:582.
37. Takemoto J.K., Bertram R.M., Remsberg C.M., Sablani S.S., Davies N.M. 13th Canadian Society for Pharmaceutical Sciences (CSPS). J. Pharm. Pharm. Sci. 2010, 13:1s.
38. How C.W., Abdullah R., Abbasalipourkabir R. Afr. J. Biotechnol. 2013, 10:1684.
39. Pouton C.W., Porter C.J.H. Adv. Drug Deliv. Rev. 2008, 60:625.
40. Lundin P.D.P., Bojrup M., Ljusberg-Wahren H., Weström B.R., Lundin S. J. Pharmacol. Exp. Ther. 1997, 282:595.
41. Lo Y.L. J. Control. Release 2003, 90:37.
42. Marier J.F., Vachon P., Gritsas A., Zhang J., Moreau J.P., Ducharme M.P. J. Pharmacol. Exp. Ther. 2002, 302:369.